Hookipa Pharma Inc (HOOK)

NASDAQ
6.170
-0.450(-6.80%)
After Hours
6.260
+0.090(+1.459%)
- Real-time Data
  • Volume:
    406,203
  • Bid/Ask:
    6.100/6.180
  • Day's Range:
    6.100 - 6.602

HOOK Overview

Prev. Close
6.62
Day's Range
6.1-6.602
Revenue
19.88M
Open
6.57
52 wk Range
6.01-19.96
EPS
-2.1
Volume
406,203
Market Cap
184.44M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
290,434
P/E Ratio
-
Beta
-
1-Year Change
-37.99%
Shares Outstanding
29,892,721
Next Earnings Date
17 Nov 2021
What is your sentiment on Hookipa Pharma Inc?
or
Market is currently closed. Voting is open during market hours.

Hookipa Pharma Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellStrong SellStrong SellSell
Technical IndicatorsSellStrong SellStrong SellStrong SellStrong Sell
SummarySellStrong SellStrong SellStrong SellStrong Sell

Hookipa Pharma Inc Company Profile

Hookipa Pharma Inc Company Profile

Employees
109

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company’s lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop infectious disease product candidates intended to support functional cures for chronic Hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc. was incorporated in 2011 and is headquartered in New York, New York.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.